查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1358027

活性药物原料药(API) 市场：依产品类型、依分子类型、按剂型、依用途、按地区

Active Pharmaceutical Ingredients Market, By Product Type, By Molecular Type, By Formulation, By Application, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 310 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球活性药物原料药（API）市场预计2023年将达2,350亿美元，预测期内（2023-2030年）年复合成长率为6.8%。

报告范围 报告详情
基准年 2022年 2023年市场规模 2350亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期年复合成长率 6.80% 2030年市场规模预测 3724亿美元
活性药物原料药的全球市场占有率(%)（按产品类型），2023 年
原料药市场-IMG1

活性药物原料药(API) 和赋形剂是药品製造中最重要的两个要素。 API是用于製造药物的原料，而赋形剂是锭剂中所含的乳糖或矿物油等物质，可作为帮助人体吸收药物的介质。药物原料药是在研发阶段和商业生产阶段采用高科技工业製程製造的。发展其他活性以对疾病的诊断、治疗、缓解、治癒或预防具有药理活性或其他直接作用，或改变身体的结构或功能。活性药物原料药（API）市场的成长可归因于某些要素，例如不同地区政府增加的资金筹措措施。例如，2020年5月，美国卫生与公众服务部（HHS）授予了一份为期四年的合同，生产治疗COVID-19及相关疾病患者的药物所需的活性药物原料药（API），宣布价值3.54亿美元为製药公司 Phlow Corporation 提供资金。

市场动态

製药公司对美国食品药物管理局（FDA）药品核准的增加预计将在预测期内进一步推动全球活性药物原料药（API）市场的成长。例如，2020年12月，美国製药公司艾莉·礼来公司宣布将增加其2型糖尿病治疗药物Trulicity疗法的剂量，增加治疗转移性肾小球滤过率（EGFR）突变非小细胞的治疗药物Cyramza的剂量肺癌，并增加被诊断为阿兹海默症的患者数量。我们的多种药物已获得美国FDA 批准，其中包括用于人类的 tauvid。

本研究的主要特点

  • 该报告对全球活性药物原料药（API）市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030年）的市场规模和平均年度（年复合成长率%）。
  • 它揭示了各个细分市场的潜在收入机会，并概述了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场促进因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、财务实绩和策略等参数，介绍了全球活性原料药(API) 市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场经营团队和行销策略做出明智的资讯。
  • 全球活性药物原料药(API) 市场报告迎合了该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过分析全球活性药物原料药(API) 市场时使用的各种策略矩阵来促进决策。

目录

第1章调查目的和假设

  • 这项研究的目的
  • 假设
  • 简称

第2章市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第3章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 影响分析
  • 法规场景
  • 市场趋势
  • API专利有效期限
  • 产能分析
  • 合併、收购和合作场景
  • 主要进展
  • PEST分析
  • 投资金筹措
  • 生产消费分析

第4章全球药物原料药(API) 市场 - COVID-19 疾病的影响分析

  • 经济影响
  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 对需求和供给的影响

第5章全球活性药物原料药（API）市场，依产品类型，2018-2030

  • 低效率 API
  • 高效API

第6章全球活性药物原料药(API) 市场，依分子类型，2018-2030

  • 低分子
  • 高分子

第7章全球活性药物原料药（API）市场，按剂型，2018-2030

  • 口服
  • 外用
  • 注射
  • 滴水

第8章全球活性药物原料药(API) 市场，依用途，2018-2030

  • 糖尿病
  • 肿瘤学
  • 心血管
  • 中枢神经系统
  • 止痛药
  • 眼科
  • 呼吸系统
  • 皮肤科
  • 其他的

第9章全球活性药物原料药（API）市场，按地区，2018-2030

  • 北美洲
  • 美国
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章竞争形势

  • 公司简介
    • Teva Pharmaceutical Industries Ltd
    • Pfizer, Inc.
    • Dr. Reddy's Laboratories Ltd
    • Novartis AG
    • Mylan NV
    • Amneal Pharmaceuticals LLC
    • Lonza Group
    • Lupin Limited
    • Fresenius Kabi
    • Hikma Pharmaceuticals
    • Cipla Limited
    • Glenmark Pharmaceuticals Limited
    • Sun Pharmaceutical Industries Ltd
    • Endo International plc
    • Aurobindo Pharma Limited
    • Apotex Inc.
    • Taro Pharmaceutical Industries Ltd
    • Stada Arzneimittel AG
    • Krka Pharmaceuticals
    • CordenPharma International
    • Evonik Industries AG
    • Biological E. Limited

第11章章节

  • 参考
  • 调查方法
简介目录
Product Code: CMI738

The global active pharmaceutical ingredients market is estimated to be valued at US$ 235 Billion in 2023 and is expected to exhibit a CAGR of 6.8% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 235 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 6.80% 2030 Value Projection: US$ 372.4 Bn
Global Active Pharmaceutical Ingredients Market Share (%), By Product Type, 2023
Active Pharmaceutical Ingredients Market - IMG1

Active pharmaceutical ingredients (APIs) and excipients are the two most important components in the production of a medication. API is the raw material that is used in manufacturing medications, whereas an excipient is a substance that functions as a medium to help the body absorb the drug, such as lactose or mineral oil in a tablet. Active pharmaceutical ingredients are produced by using highly technological industrial processes, both during the research and development and commercial production phases. Such compounds are developed to provide pharmacological activity or other direct impacts on disease diagnosis, cure, mitigation, therapy, or prevention, or to change the structure and function of the body. The growth of the active pharmaceutical ingredients (API) market can be attributed to certain factors, such as increasing funding initiatives by the government across different regions. For instance, in May 2020, the U.S. Department of Health and Human Services (HHS) announced that it will provide funding of US$ 354 million to Phlow Corporation, a pharmaceutical company, under a four-year contract to produce the active pharmaceutical ingredientss (APIs) needed for medications to treat patients with COVID-19 and related illnesses.

Market Dynamics

The rising U.S. Food and Drug Administration (FDA) approvals for drugs by pharmaceutical companies are further expected to boost the global active pharmaceutical ingredients (API) market growth during the forecast period. For instance, in December 2020, Eily Lilly, an American pharmaceutical company received U.S FDA clearance for several medicines, including increased dosages of its Trulicity therapy for the treatment of type 2 diabetes, Cyramza for the treatment of metastatic Estimated Glomerular Filteration Rate (EGFR)-mutated non-small cell lung cancer, and tauvid for individuals diagnosed with Alzheimer's disease.

Key features of the study:

  • This report provides an in-depth analysis of the global active pharmaceutical ingredients (API) market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global active pharmaceutical ingredients (API) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies.
  • Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Dr. Reddy's Laboratories Ltd., Novartis AG, Mylan N.V., Amneal Pharmaceuticals LLC, Lonza Group, Lupin Limited, Fresenius Kabi, Hikma Pharmaceuticals, Cipla Limited, Glenmark Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd., Endo International plc, Aurobindo Pharma Limited, Apotex Inc, Taro Pharmaceutical Industries Ltd, Stada Arzneimittel AG, Krka Pharmaceuticals, CordenPharma International, Evonik Industries AG, and Biological E. Limited.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global active pharmaceutical ingredients (API) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global active pharmaceutical ingredients (API) market.

Active Pharmaceutical Ingredients (API) Market Detailed Segmentation:

  • By Product Type:
    • Low Potent APIs
    • High Potent APIs
  • By Molecular Type:
    • Small Molecules
    • Large Molecules
  • By Formulation:
    • Oral
    • Topical
    • Injectables
    • Drops
  • By Application:
    • Diabetes
    • Oncology
    • Cardiovascular
    • CNS
    • Analgesics
    • Ophthalmic
    • Respiratory
    • Dermatology
    • Others
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Teva Pharmaceutical Industries Ltd
    • Pfizer, Inc.
    • Reddy's Laboratories Ltd
    • Novartis AG
    • Mylan N.V.
    • Amneal Pharmaceuticals LLC
    • Lonza Group
    • Lupin Limited
    • Fresenius Kabi
    • Hikma Pharmaceuticals
    • Cipla Limited
    • Glenmark Pharmaceuticals Limited
    • Sun Pharmaceutical Industries Ltd
    • Reddy's Laboratories Ltd
    • Endo International plc
    • Aurobindo Pharma Limited
    • Apotex Inc.
    • Taro Pharmaceutical Industries Ltd
    • Stada Arzneimittel AG
    • Krka Pharmaceuticals
    • CordenPharma International
    • Evonik Industries AG
    • Biological E. Limited

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Molecular Type
    • Market Snippet, By Formulation
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunity
  • Impact Analysis
  • Regulatory Scenario
  • Market Trends
  • API Patent Expiration
  • Production Capability Analysis
  • Mergers, Acquisitions and Collaboration Scenario
  • Key Developments
  • PEST Analysis
  • Investments & Funding
  • Production and Consumption Analysis

4. Global Active Pharmaceutical Ingredients (API) Market- COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Active Pharmaceutical Ingredients (API) Market, By Product Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Low Potent APIs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • High Potent APIs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Active Pharmaceutical Ingredients (API) Market, By Molecular Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Small Molecules
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Large Molecules
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Active Pharmaceutical Ingredients (API) Market, By Formulation, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Injectables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Drops
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Active Pharmaceutical Ingredients (API) Market, By Formulation, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Diabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • CNS
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
  • Analgesics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
  • Ophthalmic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
  • Respiratory
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
  • Dermatology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)

9. Global Active Pharmaceutical Ingredients (API) Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018-2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018-2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018-2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018-2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018-2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018-2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 -2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Company Profiles
    • Teva Pharmaceutical Industries Ltd
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Pfizer, Inc.
    • Dr. Reddy's Laboratories Ltd
    • Novartis AG
    • Mylan N.V.
    • Amneal Pharmaceuticals LLC
    • Lonza Group
    • Lupin Limited
    • Fresenius Kabi
    • Hikma Pharmaceuticals
    • Cipla Limited
    • Glenmark Pharmaceuticals Limited
    • Sun Pharmaceutical Industries Ltd
    • Endo International plc
    • Aurobindo Pharma Limited
    • Apotex Inc.
    • Taro Pharmaceutical Industries Ltd
    • Stada Arzneimittel AG
    • Krka Pharmaceuticals
    • CordenPharma International
    • Evonik Industries AG
    • Biological E. Limited

11. Section

  • References
  • Research Methodology
  • About us and Sales Contact